FDA Vaccines and Related Biological Products Advisory Panel
The location of the committee's July 20 and 21 meeting has been changed to the Hyatt Regency, 1 Bethesda Metro Center, Bethesda, Maryland, according to a July 10 Federal Register notice. The initial announcement of the meeting was issued in the June 23 Federal Register.
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.